 Orgenesis Inc NASDAQ:ORGS announced Thursday that it is collaborating with MIDA Biotech BV to establish point-of-care centers at hospitals and other medical institutions across western Europe. Orgenesis said it and MIDA plan to deploy Orgenesis Mobile Processing Units and Labs OMPULs at leading hospitals for the onsite development of promising cell and gene therapies and immunotherapies from MIDA. 